Blade revenue jumps to $24.6M in transition period; net income positive on warrant gain

Strata Critical Medical, Inc.

2022-FY EPS reported -$0.38 revenue$146,120,000

Revenue $24.6M for three months ended Dec 31, 2021, up from $8.0M in prior-year period.
Operating loss widened to $10.5M from $2.4M; net income $0.8M includes $10.9M non-cash warrant gain.
Cash and short-term investments total $282M at Dec 31, 2021; cash used in ops $6.0M.
Acquired exclusive rights to Helijet’s scheduled Canadian passenger routes for $12.4M during period.
Fiscal year changed from Sept 30 to Dec 31; audited transition-period financials filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.